{"id":"https://genegraph.clinicalgenome.org/r/2f2b504b-2aa9-4ba6-b7ab-335e5f4159fcv1.0","type":"EvidenceStrengthAssertion","dc:description":"COLGALT1 was first reported in relation to autosomal recessive brain small vessel disease 3 (BSVD3) in 2018 (Miyatake et al., PMID: 30412317). BSVD3 results from fragility of cerebral vessels causing an increased risk for intracranial bleeding. The clinical findings depend on the timing and location of the intracranial bleed and have been observed in utero and early infancy. Symptoms include developmental delay, spasticity, and porencephaly on brain imaging (Miyatake et al., PMID: 30412317). The COLGALT1 gene encodes the collagen beta galactosyltransferase 1 (ColGalT1) protein. This protein initiates glycosylation of CoL4a1, an important step in the formation of the triple helix of collagen IV (Teunissen et al., PMID: 33709034). At least 5 biallelic COLGALT1 variants (4 missense, 1 splice site) have been reported in humans. This gene-disease relationship is supported by functional evidence including expression studies and rescue experiments (Miyatake et al., PMID: 30412317; Teunissen et al., PMID: 33709034). In summary, there is moderate evidence to support this gene-disease relationship. While more evidence is needed to establish this relationship definitively, no convincing contradictory evidence has emerged. This classification was approved by the ClinGen Congenital Disorders of Glycosylation GCEP on March 6, 2025 (SOP Version 11).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/2f2b504b-2aa9-4ba6-b7ab-335e5f4159fc","GCISnapshot":"https://genegraph.clinicalgenome.org/r/8cc18e7d-fac7-435b-9207-9a3e6891e7ca","calculatedEvidenceStrength":"Moderate","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/8cc18e7d-fac7-435b-9207-9a3e6891e7ca_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10135","date":"2025-03-31T16:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/8cc18e7d-fac7-435b-9207-9a3e6891e7ca_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10135","date":"2025-03-31T19:10:13.946Z","role":"Publisher"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8cc18e7d-fac7-435b-9207-9a3e6891e7ca_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8cc18e7d-fac7-435b-9207-9a3e6891e7ca_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/11d76575-22c9-4709-92fe-ec4978172d40","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8d38e352-f45c-4010-8eec-c13161601339","type":"Finding","dc:description":"When rescued with wild-type COLGALT1, COL4A1-immunostained signals were restored to a granular pattern, which is observed in natural HT1080 cells. In cells rescued with wild-type COLGALT1, granular-patterned COL4A1 signals were observed in approximately 45% of total myc-positive transfected cells. However, when rescued with either COLGALT1 mutant, the number of myc-positive transfected cells with a granular pattern were significantly decreased (2â€“3% for cells with p.Leu151Arg and p.Ala154Pro mutant COLGALT1, and 13% for cells with p.Gly377Arg mutant COLGALT1.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30412317","rdfs:label":"Rescue Experiment","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityCellCultureRescueCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/8cc18e7d-fac7-435b-9207-9a3e6891e7ca_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ce802bf8-12ba-4b62-8ddf-1644a62c0376_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3784e9e6-ffb7-4166-877a-b8a63fd3da22","type":"EvidenceLine","dc:description":"We adjusted this score because 2 cryptic splice sites were activated, causing a frameshift in the major transcript and in-frame deletion in a minor transcript. The major transcript leads to reduced protein levels and function. The effect of the minor transcript wasn't tested. It may act as a wildtype or as a loss of function. ","calculatedScore":4,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3784e9e6-ffb7-4166-877a-b8a63fd3da22_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"The c.625-2A>C splice site variant undoubtedly results in markedly decreased CoLGaLT1 protein levels and function.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/3784e9e6-ffb7-4166-877a-b8a63fd3da22_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33709034","allele":{"id":"https://genegraph.clinicalgenome.org/r/7430a502-9cbb-4882-a9b6-6f817899c6f2","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_024656.4(COLGALT1):c.625-2A>C","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA404701587"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/ce802bf8-12ba-4b62-8ddf-1644a62c0376","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33709034","rdfs:label":"Teunissen Case 1","ageType":"AgeAtDeath","ageUnit":"Years","ageValue":3,"allele":{"id":"https://genegraph.clinicalgenome.org/r/7430a502-9cbb-4882-a9b6-6f817899c6f2"},"detectionMethod":"WES revealed a homozygous canonical splice site variant NM_024656.3:c.625-2A>C. PCR and Sanger sequencing of the mRNA demonstrated that 2 cryptic splice sites are activated, causing a frameshift in the major transcript and in-frame deletion in a minor transcript.","firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Porencephaly\nDevelopmental delay\nRefractory epilepsy\nSpastic quadriplegia\nProgressive hydrocephalus","phenotypes":["obo:HP_0002478","obo:HP_0011344","obo:HP_0032867","obo:HP_0000238"],"previousTesting":true,"previousTestingDescription":"Postnatal cerebral MRI scan revealed porencephalic cysts, multiple white matter abnormalities, and elaborate hemorrhages which were progressive. COL4A1/COL4A2-related disorder was suspected but Sanger sequencing of the COL4A! and COL4A2 genes was negative. ","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/3784e9e6-ffb7-4166-877a-b8a63fd3da22_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/3d3e2a6e-befd-429b-9217-10c97d0e1685_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dedda1e6-0ed8-4ea4-b87f-43d939b030a7","type":"EvidenceLine","dc:description":"We adjusted the scoring on this variant due to multiple levels of functional evidence. ","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dedda1e6-0ed8-4ea4-b87f-43d939b030a7_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional analysis suggested that p.Ala154Pro may be a null variant, inducing protein instability and impairing ColGalT activity similar to p.Leu151Arg.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/dedda1e6-0ed8-4ea4-b87f-43d939b030a7_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30412317","allele":{"id":"https://genegraph.clinicalgenome.org/r/74c2a70f-bb1e-40d2-a703-45be8573c7a4","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_024656.4(COLGALT1):c.460G>C (p.Ala154Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA9296904"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/1969906b-e27f-423a-af86-4959d809b0d6","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1969906b-e27f-423a-af86-4959d809b0d6_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"p.Gly377Arg may be a functionally hypomorphic variant with a milder effect on ColGalT activity based on the rescue experiment.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/1969906b-e27f-423a-af86-4959d809b0d6_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30412317","allele":{"id":"https://genegraph.clinicalgenome.org/r/58a47f31-b70e-4ce7-a121-4b0544bbece9","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_024656.4(COLGALT1):c.1129G>C (p.Gly377Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA404710666"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/3d3e2a6e-befd-429b-9217-10c97d0e1685","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30412317","rdfs:label":"Miyatake Case 2","ageType":"AgeAtReport","ageUnit":"Years","ageValue":9,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/58a47f31-b70e-4ce7-a121-4b0544bbece9"},{"id":"https://genegraph.clinicalgenome.org/r/74c2a70f-bb1e-40d2-a703-45be8573c7a4"}],"detectionMethod":"Because parental samples were unavailable for Patient 2, they phased the 2 detected variants using 2 different devices: a nanopore MinION sequencer and digital droplet PCR.","firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Poor eye contact, suspected developmental delay\nmultiple parenchymal/intraventricular hemorrages\nmicroscopic hematuria, high stature, marginal intellectual disability\nlarge stature, right hemiplegia","phenotypes":["obo:HP_0002907","obo:HP_0006994","obo:HP_0006889","obo:HP_0030746"],"previousTesting":true,"previousTestingDescription":"WES of COL4A1, COL4A2, and NOTCH3 did not show any variants.","secondTestingMethod":"PCR","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/dedda1e6-0ed8-4ea4-b87f-43d939b030a7_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/1969906b-e27f-423a-af86-4959d809b0d6_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2.0},{"id":"https://genegraph.clinicalgenome.org/r/5150eeea-fcc5-4b95-b62a-6f5bea160620_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d417d36a-2cc0-46cc-885e-97d386c98b6f","type":"EvidenceLine","dc:description":"We adjusted this score based on multiple lines of functional evidence. ","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d417d36a-2cc0-46cc-885e-97d386c98b6f_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"This variant affected ColGalt1 protein stability and ColGalt activity, leading to undetectable levels.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/d417d36a-2cc0-46cc-885e-97d386c98b6f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30412317","allele":{"id":"https://genegraph.clinicalgenome.org/r/b787a8bc-027d-4a39-a8a1-cd978221d167","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_024656.4(COLGALT1):c.452T>G (p.Leu151Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA404696667"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/568d2e69-9b18-4384-9b56-9b1c7bffccec","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/568d2e69-9b18-4384-9b56-9b1c7bffccec_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"This variant affected ColGalt1 protein stability and ColGalt activity, leading to undetectable levels.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/568d2e69-9b18-4384-9b56-9b1c7bffccec_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30412317","allele":{"id":"https://genegraph.clinicalgenome.org/r/4fcdcecc-447d-4e8a-9bb2-ffc33a5133c5","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_024656.4(COLGALT1):c.1096del (p.Glu366ArgfsTer15)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA913190498"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/5150eeea-fcc5-4b95-b62a-6f5bea160620","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30412317","rdfs:label":"Miyatake Case 1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":12,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/4fcdcecc-447d-4e8a-9bb2-ffc33a5133c5"},{"id":"https://genegraph.clinicalgenome.org/r/b787a8bc-027d-4a39-a8a1-cd978221d167"}],"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Porencephaly, motor developmental delay, epilepsy.","phenotypes":["obo:HP_0030746","obo:HP_0002478","obo:HP_0010864","obo:HP_0002352","obo:HP_0002059","obo:HP_0002133","obo:HP_0012444","obo:HP_0001252"],"previousTesting":true,"previousTestingDescription":"MRI at age 21 months showed porencephaly in the left hemisphere and bilateral leukoencephalopathy with mild atrophy. WES testing of patient and parents found no variants in COL4A1 and COL4A2. ","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/568d2e69-9b18-4384-9b56-9b1c7bffccec_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/d417d36a-2cc0-46cc-885e-97d386c98b6f_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":6.5}],"evidenceStrength":"Moderate","sequence":10165,"specifiedBy":"GeneValidityCriteria11","strengthScore":7.5,"subject":{"id":"https://genegraph.clinicalgenome.org/r/1Uw1qGM8ElY","type":"GeneValidityProposition","disease":"obo:MONDO_0100105","gene":"hgnc:26182","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_8cc18e7d-fac7-435b-9207-9a3e6891e7ca-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}